首页 | 本学科首页   官方微博 | 高级检索  
检索        

SREBPS及VEGF调节辛伐他汀对血管平滑肌细胞的作用
引用本文:张丽丽,杨国才,戴秋艳.SREBPS及VEGF调节辛伐他汀对血管平滑肌细胞的作用[J].中国医药指南,2013,0(14):8-11.
作者姓名:张丽丽  杨国才  戴秋艳
作者单位:张丽丽 (日照市人民医院心内科,山东日照,276800); 杨国才 (日照市人民医院感染科,山东日照,276800); 戴秋艳 (上海市第一人民医院心内科,上海,200080);
摘    要:目的观察辛伐他汀对血管平滑肌细胞作用,是否通过SREBPs及VEGF的调节起作用,SREBPs与VEGF之间相互关系。方法①体外培养大鼠血管平滑肌细胞(VSMCs),观察辛伐他汀对VSMCs增殖、迁移的影响及SREBPs、VEGF的mRNA表达。②建立大鼠动脉粥样硬化血管损伤模型,分为NC组、AI,组、LS组和HS组。药物干预4周后测定各组血脂、胸主动脉内膜/(内膜+中膜)比值及血管SREBPs、VEGF的mRNA表达。结果实验证明,大剂量辛伐他汀明显抑制VSMCs增殖和迁移,VSMCs的SREBP-1、SREBP-2的mRNA表达显著增加同时VEGF的表达显着减少,SREBPs与VEGF之间有一定的相关性。结论辛伐他汀抑制血管平滑肌细胞增殖和迁移机制可能是通过增加VSMCs的SREBPs的表达进而减少VEGF表达。

关 键 词:血管平滑肌细胞  辛伐他汀  固醇调节素结合蛋白  血管内皮生长因子

Effect of Sterol Regulatory Element Binding Proteins and Vascular Endothelial Growth Factor Regulating Simvastatin on Vascular Smooth Muscle Cells
ZHANG Li-li,YANG Cruo-cai,DAI Qiu-yan.Effect of Sterol Regulatory Element Binding Proteins and Vascular Endothelial Growth Factor Regulating Simvastatin on Vascular Smooth Muscle Cells[J].Guide of China Medicine,2013,0(14):8-11.
Authors:ZHANG Li-li  YANG Cruo-cai  DAI Qiu-yan
Institution:1 Department of Cardiology, People's Hospital of Rizhao, Rizhao 276800, China; 2 Department of Infectious Diseases, People's Hospital ofRizhao, Rizhao 276800, China; 3 Department of Cardiology, Shanghai First People's Hospital, Shanghai 200080, China)
Abstract:Objective To investigate the biphasic effect of simvastatins on vascular smooth muscle cells (VSMCs) and the possible mechanism regulated by Sterol Regulatory Element Binding Proteins (SREBPs) and Vascular Endothelial Growth Factor (VEGF). To explore the relationship between SREBPs and VEGF. Methods 0)To investigate the effect of simvastatin on the proliferation and migration of VSMCs and the SREBP-1, SREBP-2 and VEGF mRNA expression of VSMCs by primary VSMCs culture in vitro. 2 The atherosclerotie vessel injured model was established and randomly divide into four groups. Normal control group, atheroselerotic injured group, low-dose simvastatin group, and high-dose simvastatin group. After 4 weeks simvastatin intervention, the serum lipid and the ratio of intima/(intima + tuniea media) of thoracic aorta were detected. The mRNA expression of SREBP-1, SREBP-2 and VEGF on blood vessel were also determined. Results High dose simvastatin inhibited the proliferation and migration of VSMCs. Moreover, high-concentration simvastatin could significantly activate SREBP-1 and SREBP-2 mRNA expression while obviously reduce the VEGF mRNA expression ofVSMCs. SREBPs and VEGF have some relationship. Conclusion Simvastatin inhibit the proliferation and migration of VSMCs via activating SREBPs expression and then decreasing the expression of VEGF in VSMCs.
Keywords:VSMCs  Simvastatin  SREBPs  VEGF
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号